Clinical Trial Update: Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia [NA]

View source ↗

Summary

A completed clinical trial investigated whether terbutaline use or reducing basal insulin can prevent nocturnal hypoglycemia in type 1 diabetes; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Terbutaline (terbutaline)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2013-10-11